(Q37068910)

18 August 2017

1 reference

title

Use of bone morphogenetic proteins for treatment of non-unions and future perspectives (English)

1 reference

18 August 2017

1 reference

Schmidmaier G

1

1 reference

18 August 2017

Schwabe P

series ordinal

2

1 reference

18 August 2017

Wildemann B

series ordinal

3

1 reference

18 August 2017

Haas NP

series ordinal

4

1 reference

18 August 2017

publication date

1 September 2007

1 reference

18 August 2017

1 reference

18 August 2017

volume

38 Suppl 4

1 reference

18 August 2017

page(s)

S35-41

1 reference

Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: the German model

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Drugs and fracture repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Direct percutaneous gene delivery to enhance healing of segmental bone defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Biophysical stimulation of bone fracture repair, regeneration and remodelling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Application of recombinant BMP-7 on persistent upper and lower limb non-unions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Current concepts of molecular aspects of bone healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Allograft and alloplastic bone substitutes: a review of science and technology for the craniomaxillofacial surgeon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Bone-grafting and bone-graft substitutes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Osteointegration and implant position after cementless total knee replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Bone substitutes: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Clinical applications of BMP-7: the UK perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Application of bone morphogenetic proteins in orthopaedic practice: their efficacy and side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

IGF-I and TGF-beta1 application by a poly-(D,L-lactide)-coated cage promotes intervertebral bone matrix formation in the sheep cervical spine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Bone morphogenic protein science and studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

rhBMP‐2 injected in a calcium phosphate paste (α‐BSM) accelerates healing in the rabbit ulnar osteotomy model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Factors stimulating bone formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Safety profile for the clinical use of bone morphogenetic proteins in the spine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Modern issues in bone graft substitutes and advances in bone tissue technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Adult posttraumatic osteomyelitis of the tibial diaphysis of the tibial shaft.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

The role of growth factors and related agents in accelerating fracture healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Differential repair responses in the coronal and radicular areas of the exposed rat molar pulp induced by recombinant human bone morphogenetic protein 7 (osteogenic protein 1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Complications of posterior iliac crest bone grafting in spine surgery in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Telopeptide-depleted bovine skin collagen as a carrier for bone morphogenetic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Bone: formation by autoinduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Recombinant human bone morphogenetic protein induces bone formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Local delivery of growth factors from coated titanium plates increases osteotomy healing in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Novel regulators of bone formation: molecular clones and activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-1383%2808%2970007-X

10.1016/S0020-1383(08)70007-X

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference